BACKGROUND: Effectiveness of medical therapies in chronic pancreatitis has been described in small studies of selected patients. AIM: To describe frequency and perceived effectiveness of non-analgesic medical therapies in chronic pancreatitis patients evaluated at US referral centres. METHODS: Using data on 516 chronic pancreatitis patients enrolled prospectively in the NAPS2 Study, we evaluated how often medical therapies [pancreatic enzyme replacement therapy (PERT), vitamins/antioxidants (AO), octreotide, coeliac plexus block (CPB)] were utilized and considered useful by physicians. RESULTS: Oral PERT was commonly used (70%), more frequently in the presence of exocrine insufficiency (EI) (88% vs. 61%, P < 0.001) and pain (74% vs. 59%, P < 0.002). On multivariable analyses, predictors of PERT usage were EI (OR 5.14, 95% CI 2.87-9.18), constant (OR 3.42, 95% CI 1.93-6.04) or intermittent pain (OR 1.98, 95% CI 1.14-3.45). Efficacy of PERT was predicted only by EI (OR 2.16, 95% CI 1.36-3.42). AO were tried less often (14%) and were more effective in idiopathic and obstructive vs. alcoholic chronic pancreatitis (25% vs. 4%, P = 0.03). Other therapies were infrequently used (CPB - 5%, octreotide - 7%) with efficacy generally <50%. CONCLUSIONS: Pancreatic enzyme replacement therapy is commonly utilized, but is considered useful in only subsets of chronic pancreatitis patients. Other medical therapies are used infrequently and have limited efficacy.
BACKGROUND: Effectiveness of medical therapies in chronic pancreatitis has been described in small studies of selected patients. AIM: To describe frequency and perceived effectiveness of non-analgesic medical therapies in chronic pancreatitispatients evaluated at US referral centres. METHODS: Using data on 516 chronic pancreatitispatients enrolled prospectively in the NAPS2 Study, we evaluated how often medical therapies [pancreatic enzyme replacement therapy (PERT), vitamins/antioxidants (AO), octreotide, coeliac plexus block (CPB)] were utilized and considered useful by physicians. RESULTS: Oral PERT was commonly used (70%), more frequently in the presence of exocrine insufficiency (EI) (88% vs. 61%, P < 0.001) and pain (74% vs. 59%, P < 0.002). On multivariable analyses, predictors of PERT usage were EI (OR 5.14, 95% CI 2.87-9.18), constant (OR 3.42, 95% CI 1.93-6.04) or intermittent pain (OR 1.98, 95% CI 1.14-3.45). Efficacy of PERT was predicted only by EI (OR 2.16, 95% CI 1.36-3.42). AO were tried less often (14%) and were more effective in idiopathic and obstructive vs. alcoholic chronic pancreatitis (25% vs. 4%, P = 0.03). Other therapies were infrequently used (CPB - 5%, octreotide - 7%) with efficacy generally <50%. CONCLUSIONS:Pancreatic enzyme replacement therapy is commonly utilized, but is considered useful in only subsets of chronic pancreatitispatients. Other medical therapies are used infrequently and have limited efficacy.
Authors: Dhiraj Yadav; Robert H Hawes; Randall E Brand; Michelle A Anderson; Mary E Money; Peter A Banks; Michele D Bishop; John Baillie; Stuart Sherman; James DiSario; Frank R Burton; Timothy B Gardner; Stephen T Amann; Andres Gelrud; Christopher Lawrence; Beth Elinoff; Julia B Greer; Michael O'Connell; M Michael Barmada; Adam Slivka; David C Whitcomb Journal: Arch Intern Med Date: 2009-06-08
Authors: David C Whitcomb; Dhiraj Yadav; Slivka Adam; Robert H Hawes; Randall E Brand; Michelle A Anderson; Mary E Money; Peter A Banks; Michele D Bishop; John Baillie; Stuart Sherman; James DiSario; Frank R Burton; Timothy B Gardner; Stephen T Amann; Andres Gelrud; Simon K Lo; Mark T DeMeo; William M Steinberg; Michael L Kochman; Babak Etemad; Christopher E Forsmark; Beth Elinoff; Julia B Greer; Michael O'Connell; Janette Lamb; M Michael Barmada Journal: Pancreatology Date: 2008-09-03 Impact factor: 3.996
Authors: Tobias Keck; Goran Marjanovic; Carlos Fernandez-del Castillo; Frank Makowiec; Arndt Oliver Schäfer; J Ruben Rodriguez; Oswaldo Razo; Ulrich Theodor Hopt; Andrew L Warshaw Journal: Ann Surg Date: 2009-01 Impact factor: 12.969
Authors: Asbjørn M Drewes; Maciej Gratkowski; Saber A K Sami; Georg Dimcevski; Peter Funch-Jensen; Lars Arendt-Nielsen Journal: World J Gastroenterol Date: 2008-07-07 Impact factor: 5.742
Authors: Kenneth E Fasanella; Brian Davis; John Lyons; Zongfu Chen; Kenneth K Lee; Adam Slivka; David C Whitcomb Journal: Gastroenterol Clin North Am Date: 2007-06 Impact factor: 3.806
Authors: Mark Lazarev; Janette Lamb; M Michael Barmada; Feng Dai; Michelle A Anderson; Mitchell B Max; David C Whitcomb Journal: Mol Pain Date: 2008-11-17 Impact factor: 3.395
Authors: Michelle A Anderson; Venkata Akshintala; Kathryn M Albers; Stephen T Amann; Inna Belfer; Randall Brand; Suresh Chari; Greg Cote; Brian M Davis; Luca Frulloni; Andres Gelrud; Nalini Guda; Abhinav Humar; Rodger A Liddle; Adam Slivka; Rachelle Stopczynski Gupta; Eva Szigethy; Jyothsna Talluri; Wahid Wassef; C Mel Wilcox; John Windsor; Dhiraj Yadav; David C Whitcomb Journal: Pancreatology Date: 2015-11-11 Impact factor: 3.996
Authors: Søren S Olesen; Jacob Juel; Carina Graversen; Yuri Kolesnikov; Oliver H G Wilder-Smith; Asbjørn M Drewes Journal: World J Gastroenterol Date: 2013-11-14 Impact factor: 5.742
Authors: Lisa M Glass; David C Whitcomb; Dhiraj Yadav; Joseph Romagnuolo; Elizabeth Kennard; Adam A Slivka; Randall E Brand; Michelle A Anderson; Peter A Banks; Michele D Lewis; John Baillie; Stuart Sherman; Samer Alkaade; Stephen T Amann; James A Disario; Michael O'Connell; Andres Gelrud; Christopher E Forsmark; Timothy B Gardner Journal: Pancreas Date: 2014-05 Impact factor: 3.327
Authors: Joseph Romagnuolo; Jyothsna Talluri; Elizabeth Kennard; Bimaljit S Sandhu; Stuart Sherman; Gregory A Cote; Samer Al-Kaade; Timothy B Gardner; Andres Gelrud; Michele D Lewis; Christopher E Forsmark; Nalini M Guda; Darwin L Conwell; Peter A Banks; Thiruvengadam Muniraj; Stephen R Wisniewski; Ye Tian; C Mel Wilcox; Michelle A Anderson; Randall E Brand; Adam Slivka; David C Whitcomb; Dhiraj Yadav Journal: Pancreas Date: 2016-08 Impact factor: 3.327
Authors: Darwin L Conwell; Peter A Banks; Bimaljit S Sandhu; Stuart Sherman; Samer Al-Kaade; Timothy B Gardner; Michelle A Anderson; C Mel Wilcox; Michele D Lewis; Thiruvengadam Muniraj; Christopher E Forsmark; Gregory A Cote; Nalini M Guda; Ye Tian; Joseph Romagnuolo; Stephen R Wisniewski; Randall Brand; Andres Gelrud; Adam Slivka; David C Whitcomb; Dhiraj Yadav Journal: Dig Dis Sci Date: 2017-06-09 Impact factor: 3.199